HBM Healthcare Investments
| HBM Healthcare Investments AG
|
|
|---|---|
 |
|
| legal form | Corporation |
| ISIN | CH0012627250 |
| founding | July 12, 2001 |
| Seat | Zug , Switzerland |
| management | Andreas Wicki (Chairman of the Management Board ) Hans Peter Hasler ( Chairman of the Board of Directors ) |
| Branch | Holding company |
| Website | www.hbmhealthcare.com |
HBM Healthcare Investments AG (formerly HBM BioVentures AG ), based in Zug, is a Swiss investment company .
HBM Healthcare Investments is invested in around 25 companies worldwide in the fields of human medicine, biotechnology, medical technology and diagnostics as well as related areas, whose main products are in advanced development or have already been launched on the market. The market value of the investments at the end of March 2016 was 976.6 million Swiss francs. HBM Healthcare Investments is listed on the SIX Swiss Exchange (symbol: HBMN).
The company was founded in 2001 by Henri B. Meier as HBM Bioventures AG .
Web links
Individual evidence
- ↑ Archived copy ( memento of the original dated August 29, 2016 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. HBM Healthcare Investments AG, accessed on August 22, 2016 (PDF; 5.5 MB).
- ↑ Birgit Voigt: Capital shortage at HBM Bioventures . In: Neue Zürcher Zeitung , March 15, 2009, accessed on August 21, 2016.
- ^ Henri B. Meier launches HBM Bioventures AG, a new biotech investment firm . Reuters, May 21, 2001, accessed August 21, 2016.
